PDCD1 and neoplasm: The anti-programmed cell death 1 (PD-1)/anti-programmed cell death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) block immune checkpoint pathways, activating a tumor specific T cell immune response [2].